Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Francesco Oddone. (2022) Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability. Expert Opinion on Drug Safety 21:10, pages 1259-1268.
Read now
Read now
Yuan Fang, Zhihong Ling & Xinghuai Sun. (2015) Fixed-combination treatments for intraocular hypertension in Chinese patients – focus on bimatoprost-timolol. Drug Design, Development and Therapy 9, pages 2617-2625.
Read now
Read now
Nathan M Radcliffe. (2014) The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies. Clinical Ophthalmology 8, pages 2541-2549.
Read now
Read now
Joanna H Campbell, Gail F Schwartz, Britni LaBounty, Jonathan W Kowalski & Vaishali D Patel. (2014) Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions. Clinical Ophthalmology 8, pages 927-935.
Read now
Read now
Stefan Pfennigsdorf, Leo de Jong, Stefan Makk, Yvette Fournichot, Alain Bron, Robert J Morgan-Warren & John Maltman. (2013) A combined analysis of five observational studies evaluating the efficacy and tolerability of bimatoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 7, pages 1219-1225.
Read now
Read now
Ana Sanseau, Juan Sampaolesi, Emilio Rintaro Suzuki$suffix/text()$suffix/text(), Joao Franca Lopes & Hector Borel. (2013) Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/timolol among patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 7, pages 357-362.
Read now
Read now
Yang Liu & Weiming Mao. (2013) Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma. Clinical Ophthalmology 7, pages 7-14.
Read now
Read now
Articles from other publishers (22)
Masaru Inatani, Yusuke Orii, Kentaro Iwasaki, Shogo Arimura, Hiromi Sunagawa, Minako Shiokawa, Kenji Inoue, Takuto Sakono, Takato Sakono, Rika Kuwamura, Akiko Yoshida, Junko Oi, Yasuaki Kuwayama, Kiyoshi Kano, Noriaki Kido, Akiko Matsuyama, Mineo Ozaki, Hideki Abe, Chizuru Inoue, Satoko Nakagawa, Kunihiro Musashi, Akiyasu Kanamori, Jinhee Lee, Shinichiro Otani, Ryota Aoki, Hirotaka Tanabe, Shunsuke Nakakura, Katsuyoshi Suzuki, Takeshi Sagara, Yoshiaki Saito, Motoyasu Sameshima, Mai Urahashi, Fumika Watanabe-Kitamura, Toshihiro Inoue, Fumie Kagaya, Yusuke Murai, Sotaro Mori, Kaori Ueda, Takuji Kurimoto, Yuko Yamada-Nakanishi, Makoto Nakamura, Takehiro Yamashita, Sosuke Ishiyama, Shinichi Manabe, Keiko Takaki, Ken Hayashi, Akiko Ishida, Aika Tsutsui, Kaoru Manabe & Masaki Tanito. (2023) Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study. Advances in Therapy 40:9, pages 4074-4092.
Crossref
Crossref
E. Ansari, S. Chappiti, J. Pavicic-Astalos, J. C. Pinto-Bonilla, I. Riva, M. Sacchi & F. Saénz-Francés. (2022) Treatment of open-angle glaucoma and ocular hypertension with preservative-free tafluprost/timolol fixed-dose combination therapy: 6 case reports and clinical outcomes. BMC Ophthalmology 22:1.
Crossref
Crossref
Tao Wang, Linlin Cao, Qikun Jiang & Tianhong Zhang. (2021) Topical Medication Therapy for Glaucoma and Ocular Hypertension. Frontiers in Pharmacology 12.
Crossref
Crossref
Makoto Aihara. (2021) Prostanoid receptor agonists for glaucoma treatment. Japanese Journal of Ophthalmology 65:5, pages 581-590.
Crossref
Crossref
Jie Shen, Rex A. Moats, Harvey A. Pollack, Michael R. Robinson & Mayssa Attar. (2020) Distribution of 14C-Latanoprost Following a Single Intracameral Administration Versus Repeated Topical Administration. Ophthalmology and Therapy 9:4, pages 929-940.
Crossref
Crossref
Chun Hing Ho & Jasper K. W. Wong. (2019) Role of 24-Hour Intraocular Pressure Monitoring in Glaucoma Management. Journal of Ophthalmology 2019, pages 1-13.
Crossref
Crossref
Susan S. LeeMohammed DibasAlexandra AlmazanMichael R. Robinson. (2019) Dose–Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure. Journal of Ocular Pharmacology and Therapeutics 35:3, pages 138-144.
Crossref
Crossref
Jennifer R. SealMichael R. RobinsonJames BurkeMarina BejanianMichael CooteMayssa Attar. (2019) Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues. Journal of Ocular Pharmacology and Therapeutics 35:1, pages 50-57.
Crossref
Crossref
Toyoaki Tsumura, Kenji Kashiwagi, Yasuyuki Suzuki, Keiji Yoshikawa, Hirotaka Suzumura, Toshine Maeda, Ryuji Takeda, Hitomi Saito & Makoto Araie. (2018) A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan. International Ophthalmology 39:2, pages 375-383.
Crossref
Crossref
Simin Zhu, Dabo Wang & Jing Han. (2018) Effect of a Topical Combination of Latanoprost and Pranoprofen on Intraocular Pressure and the Ocular Surface in Open-Angle Glaucoma Patients. Journal of Ophthalmology 2018, pages 1-7.
Crossref
Crossref
Gábor Holló, Andreas Katsanos, Kostas G. Boboridis, Murat Irkec & Anastasios G. P. Konstas. (2017) Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages. Drugs 78:1, pages 39-64.
Crossref
Crossref
Anastasios G. P. Konstas, Luciano Quaranta, Banu Bozkurt, Andreas Katsanos, Julian Garcia-Feijoo, Luca Rossetti, Tarek Shaarawy, Norbert Pfeiffer & Stefano Miglior. (2016) 24-h Efficacy of Glaucoma Treatment Options. Advances in Therapy 33:4, pages 481-517.
Crossref
Crossref
Anastasios G.P. Konstas, Andreas Katsanos, Luciano Quaranta, Dimitrios G. Mikropoulos, Paris G. Tranos & Miguel A. Teus. 2015. New Trends in Basic and Clinical Research of Glaucoma: A Neurodegenerative Disease of the Visual System, Part B. New Trends in Basic and Clinical Research of Glaucoma: A Neurodegenerative Disease of the Visual System, Part B
297
318
.
Harvey B DuBiner & Douglas A Hubatsch. (2014) Late-day intraocular pressure–lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial. BMC Ophthalmology 14:1.
Crossref
Crossref
F. Aptel, A. Labbé, C. Baudouin, A. Bron, Y. Lachkar, E. Sellem, J.-P. Renard, J.-P. Nordmann, J.-F. Rouland & P. Denis. (2014) Traitement du glaucome, conservateurs et surface oculaire. Journal Français d'Ophtalmologie 37:9, pages 728-736.
Crossref
Crossref
Tamer A. Macky. (2014) Bimatoprost/Timolol Versus Travoprost/Timolol Fixed Combinations in an Egyptian Population. Journal of Glaucoma 23:8, pages 561-566.
Crossref
Crossref
Ivano Riva, Andreas Katsanos, Irene Floriani, Elena Biagioli, Anastasios G.P. Konstas, Marco Centofanti & Luciano Quaranta. (2014) Long-term 24-hour Intraocular Pressure Control With Travoprost Monotherapy in Patients With Primary Open-angle Glaucoma. Journal of Glaucoma 23:8, pages 535-540.
Crossref
Crossref
Daniel D. Long, Bryan Frieman, Sharath S. Hegde, Craig M. Hill, Lan Jiang, Samuel Kintz, Daniel G. Marquess, Hans Purkey, Jeng-Pyng Shaw, Tod Steinfeld, Michael S. Wilson & Kevin Wrench. (2013) A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma. Bioorganic & Medicinal Chemistry Letters 23:4, pages 939-943.
Crossref
Crossref
Cory Swymer & Michael W Neville. (2012) Tafluprost: The First Preservative-Free Prostaglandin to Treat Open-Angle Glaucoma and Ocular Hypertension. Annals of Pharmacotherapy 46:11, pages 1506-1510.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Nephrology & Hypertension 21:5, pages 557-566.
Crossref
Crossref
Florent Aptel, Christophe Chiquet & Jean-Paul Romanet. (2012) Intraocular Pressure-Lowering Combination Therapies with Prostaglandin Analogues. Drugs 72:10, pages 1355-1371.
Crossref
Crossref
Kenji Kashiwagi. (2012) Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy. Japanese Journal of Ophthalmology 56:4, pages 339-345.
Crossref
Crossref